About: Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1999 (uk) article scientifique publié en 1999 (fr) im März 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1999 (ast) scientific article published on 01 March 1999 (en)
publication date	wds:Q74449994-842BCF72-9B1E-439B-9DA0-63D266F34EC7
publication date	1999-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74449994-1B4DDB58-CAD3-4D1F-A28B-1C18686FEA2B
language of work or name	English
author name string	wds:Q74449994-149263C6-8C6F-48CA-A9A5-44CF50119C97 wds:Q74449994-2804BC13-DDF6-495F-AE7F-F2DCD40E2859 wds:Q74449994-465A296F-D4C7-46A2-BD16-41844934D579 wds:Q74449994-8E04877E-5DB2-40B1-BA62-D5EAFB71561A wds:Q74449994-9A7FD5BC-6E29-463B-A172-5030013F8460 wds:Q74449994-A7BD563C-B376-457E-9B0F-54538DA73F36 wds:Q74449994-EA633EDF-DB60-4036-ACE5-914C200C54DC
author name string	Simon J Schulman CC Zlotta AR Van Vooren JP Drowart A Noel JC Fayt I
rdfs:label	Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (en) Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (nl)
skos:prefLabel	Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (en) Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (nl)
name	Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (en) Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (nl)
author	wds:Q74449994-3A64C11F-393C-4DFD-BDA7-3D4341DEAF87
author	Kris Huygen
title	wds:Q74449994-7BC797EF-C104-4645-BECE-BD31BEFD5353
title	Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy (en)
page(s)	wds:Q74449994-7A3F0D57-EE41-4210-9E40-58382DF281C7
page(s)	792-798
instance of	wds:Q74449994-5E078A90-36D1-40EF-A1B2-C595CD11B027
instance of	scholarly article
main subject	wds:Q74449994-9495DCC7-B3F9-4E74-8AD3-AD4F9C372843
main subject	bladder cancer
PubMed ID	wds:Q74449994-1DDD7465-7FB8-4594-9CD9-002F140E5DE2
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10022686
PubMed ID	10022686
published in	wds:Q74449994-F8482C14-3911-4E3C-A911-D899255D81F4
published in	Journal of Urology
issue	wds:Q74449994-94A80BD9-7944-4654-80BF-41CA4A1D2D91
volume	wds:Q74449994-7A9230CD-6590-4B1A-A801-CD4950164583
issue	3
volume	161
DOI	wds:Q74449994-6D2C70CA-EF25-458C-A0A3-5E9943691149
DOI	http://dx.doi.org/10.1016/S0022-5347(01)61770-1
DOI	10.1016/S0022-5347(01)61770-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74449994
is cites work of	Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy? [Multivariate analysis of recurrence and progression in stage T1 transitional-cell carcinoma of the bladder. Prognostic value of p53 and Ki67] P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma Biological markers in superficial bladder tumors and their prognostic significance Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette-Guerin Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now? p53 immunohistochemistry in bladder cancer. Combined analysis: a way to go? p53 immunohistochemistry in bladder cancer--a new approach to an old question High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder Prognostic value of p53 and Ki-67 expression in intermediate-risk patients with nonmuscle-invasive bladder cancer receiving adjuvant intravesical mitomycin C therapy Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer Mutation of cell cycle regulators and their impact on superficial bladder cancer Molecular pathology of non-invasive urothelial carcinomas (part I) [Prognostic value for progression of the regulating proteins of the cellular cycle in PT1G3 bladder tumours]. [Relationship between tumor recurrence and the expression of the p53 gene in primary superficial transitional carcinoma of the bladder] Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies Management of carcinoma in situ of the bladder: best practice and recent developments Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy Prognostic value of p53 overexpression in T1G3 bladder tumors treated with bacillus Calmette-Guérin therapy Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas Expression of Smad4, TGF-βRII, and p21(waf1) in esophageal squamous cell carcinoma tissue p53-independent upregulation of p21WAF1 in NIH 3T3 cells malignantly transformed by mot-2. p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis [DNA ploidy determination with flow cytometry, Ki-67 index and overexpression of p53 protein in 121 T1 superficial bladder carcinomas. Retrospective studies. Part II: Prognostic value and usefulness in the indication for prophylactic treatment with [Comparative study of the expression of p53, Ki-67, bcl-2 and CK20 in superficial transitional carcinoma of the bladder: correlation with recurrence, histological grade, and clinical stage] Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy. [Reply to the letter: "In reference to the article: Multivariate analysis of recurrence and progression of stage T1 transitional cell carcinoma of the bladder. Prognostic value of p53 and kI67] Cyclin D3 gene amplification in bladder carcinoma in situ Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review. P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.
is cites work of	wds:Q33851162-60B8EBA1-9D4D-4F9B-BC11-68700FFD70C0 wds:Q36038105-DFF89608-8A56-456B-ACF5-E61F7E3C8E0E wds:Q43699607-55CC3492-F424-45AF-963A-18A96D642999 wds:Q44680815-9CAA6B3C-0715-4198-9F4E-E7600EAADA30

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software